Health Systems

More from the Series

Blog Post
Scoping the Indirect Health Effects of COVID-19: An Open Call for Resources
April 23, 2020
An open call for resources on the indirect impact of COVID-19 on health systems.
Blog Post
Does One Size Fit All? Realistic Alternatives for COVID-19 Response in Low-Income Countries
April 02, 2020
In the response to the COVID-19 pandemic, it is now evident that many of the public health and hospital-based interventions deployed by high-income countries may be ineffective or infeasible in low- and middle-income countries. We suggest a different order of priority for immediate next steps. ...
BRIEFS
Tackling the Triple Transition in Global Health Procurement (brief)
July 02, 2019
There have been impressive gains in global health over the past 20 years, with millions of lives saved through expanded access to essential medicines and other health products. But behind these successes is an unacceptable reality: in many low- and middle-income countries, lifesaving health products...
CGD NOTES
Modicare Post-Election: Recommendations to Enhance the Impact of Public Health Insurance on UHC Goals in India
May 11, 2019
Hailed as one of the largest publicly funded health insurance programs in the world, India’s “Modicare” has, since its launch a little more than six months ago, made universal healthcare coverage an election theme for the first time in the country’s history. 
WORKING PAPERS
Who Benefits from Pharmaceutical Price Controls? Evidence from India - Working Paper 509
April 23, 2019
With the goal of driving down drug costs, governments across the globe have instituted various forms of pharmaceutical price control policies. In this paper, we examine the theoretical and empirical effects of one implementation of pharmaceutical price controls, in which the Indian government placed...
The Future of Global Health Procurement: Background Research
April 15, 2019
Background research and resources from CGD's growing porfolio on the future of global health procurement.